Filing Details

Accession Number:
0001576280-21-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-07 17:08:36
Reporting Period:
2021-04-05
Accepted Time:
2021-04-07 17:08:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1501915 Samir Kaul 2128 Sand Hill Road
Menlo Park CA 94025
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-05 400 $155.91 24,543 No 4 S Indirect By Trust
Common Stock Disposition 2021-04-05 500 $156.95 24,043 No 4 S Indirect By Trust
Common Stock Disposition 2021-04-05 1,100 $158.21 22,943 No 4 S Indirect By Trust
Common Stock Disposition 2021-04-05 2,435 $159.18 20,508 No 4 S Indirect By Trust
Common Stock Disposition 2021-04-05 565 $159.85 19,943 No 4 S Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
No 4 S Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,059 Direct
Footnotes
  1. These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $155.48 to $156.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within each of the ranges set forth in this Form.
  3. Consists of securities held of record by a trust for the benefit of Mr. Kaul and his family.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $156.66 to $157.30 inclusive.
  5. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.67 to $158.61 inclusive.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.69 to $159.68 inclusive.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.69 to $159.97 inclusive.